Cure rates are climbing, and so is the complexity of getting there. Dr Yara Abdou takes a closer look at optimizing HER2+ early-stage breast cancer therapy.
Menopausal hormone therapy no longer has the highest-level warning label about the risk of breast cancer, opening a gray area ...
For women with early-stage breast cancer, breast-conserving therapy (BCT)—including radiation therapy (RT)—leads to progressive reduction in breast size over time, reports a study in Plastic and ...
Hormone therapy for breast cancer is not the same as hormone replacement therapy at menopause, in which hormones are given to reduce the symptoms that can be associated with menopause.
Pooled across 34 studies data from 4.5+ million women showed that MHT use increased breast cancer odds by 15% versus non-use, but regimen-specific effects dominated the aggregate estimate.
Doru Paul, MD, is a board-certified oncologist and hematologist. He is an associate professor of clinical medicine at Weill Cornell Medical College. Breast cancer treatment includes an array of ...
In women with a history of breast cancer, using hormone replacement therapy (HRT) didn’t increase the risk of breast cancer recurrence or death. The findings of this latest, small study add to a ...
Women with de novo metastatic breast cancer that is confined to a single distant organ may live longer when they undergo resection of the primary tumor, a large cohort study suggested. The study, of ...
In this review, we provide a concise overview of neoadjuvant systemic therapy in early-stage HER2-positive breast cancer, with a focus on various chemotherapy backbones and de-escalation strategies.
A discovery in mice reveals why fasting enhances a type of breast cancer treatment — a hormone-signalling pathway and gene-expression changes have key roles. Stephen D. Hursting is in the Department ...
Emerging from the battle with breast cancer is a triumph like no other. You’ve faced the fear, endured the treatments, and emerged victorious. But for many survivors, the journey doesn’t end with ...
More physicians are discussing hormone replacement therapy with breast cancer survivors when menopause hits.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results